Global Health Ltd
NSE:MEDANTA
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
903.15
1 487.05
|
Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one MEDANTA stock under the Base Case scenario is 792.23 INR. Compared to the current market price of 1 113.65 INR, Global Health Ltd is Overvalued by 29%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Global Health Ltd
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for MEDANTA cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Economic Moat
Global Health Ltd
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Global Health Ltd
Balance Sheet Decomposition
Global Health Ltd
Current Assets | 15.1B |
Cash & Short-Term Investments | 12.1B |
Receivables | 2.2B |
Other Current Assets | 837.1m |
Non-Current Assets | 28B |
Long-Term Investments | 272.3m |
PP&E | 26.2B |
Intangibles | 55.4m |
Other Non-Current Assets | 1.4B |
Current Liabilities | 6.2B |
Accounts Payable | 1.9B |
Other Current Liabilities | 4.3B |
Non-Current Liabilities | 7.8B |
Long-Term Debt | 6.3B |
Other Non-Current Liabilities | 1.5B |
Earnings Waterfall
Global Health Ltd
Revenue
|
33.5B
INR
|
Cost of Revenue
|
-7.9B
INR
|
Gross Profit
|
25.6B
INR
|
Operating Expenses
|
-19.5B
INR
|
Operating Income
|
6.1B
INR
|
Other Expenses
|
-1.3B
INR
|
Net Income
|
4.8B
INR
|
Free Cash Flow Analysis
Global Health Ltd
INR | |
Free Cash Flow | INR |
MEDANTA Profitability Score
Profitability Due Diligence
Global Health Ltd's profitability score is 60/100. The higher the profitability score, the more profitable the company is.
Score
Global Health Ltd's profitability score is 60/100. The higher the profitability score, the more profitable the company is.
MEDANTA Solvency Score
Solvency Due Diligence
Global Health Ltd's solvency score is 77/100. The higher the solvency score, the more solvent the company is.
Score
Global Health Ltd's solvency score is 77/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
MEDANTA Price Targets Summary
Global Health Ltd
According to Wall Street analysts, the average 1-year price target for MEDANTA is 1 225.7 INR with a low forecast of 863.55 INR and a high forecast of 1 512 INR.
Dividends
Current shareholder yield for MEDANTA is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Global Health Ltd. engages in the provision of healthcare, pathology, and other medical services. The company is headquartered in New Delhi, Delhi and currently employs 9,350 full-time employees. The company went IPO on 2022-11-16. Medanta delivers advanced, end-to-end healthcare in Delhi, Gurugram, Indore, Ranchi, Patna and Lucknow through its network of five hospitals, six Mediclinic, diagnostic laboratories, homecare and telemedicine services. The company provides treatments for coronary artery disease, head and neck cancer, acute myeloid leukemia, epilepsy, hip fracture, Parkinson's disease, refractive error, prostate cancer, chronic kidney disease, cerebral stroke, sepsis, liver cirrhosis, rheumatoid, arthritis, hypertension, diabetes, bronchial asthma, stomach cancer, and chronic otitis media. Medanta specializes in cardiac surgery, nephrology, urology, andrology, dermatology, ophthalmology, radiology and imaging, dental sciences, and interventional cardiology, among others. Its facilities and services include medicine delivery, air ambulance, patient support services, and others.
Contact
IPO
Employees
Officers
The intrinsic value of one MEDANTA stock under the Base Case scenario is 792.23 INR.
Compared to the current market price of 1 113.65 INR, Global Health Ltd is Overvalued by 29%.